Home » Topics » Regulatory » Patents

Patents
RSS

Prenyl-protein transferase inhibitors reported by Merck & Co.

Jan. 3, 1997

Antidementia agents reported by Eisai

Jan. 2, 1997

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

Anti-gp130 MAbs for inflammatory disorders and myeloma

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

Novel antiangiogenic compounds from ADIR

Jan. 2, 1997

Natural antitumor/antifungal agent disclosed by Fujisawa

Dec. 31, 1996

Dolastatin 10 derivatives from Teikoku Hormone

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...